Trial Profile
Phase II study of neoadjuvant chemotherapy with SOX + bevacizumab in patients with locally advanced rectal cancer
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 12 May 2016
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Gimeracil/oteracil/tegafur; Oxaliplatin
- Indications Rectal cancer
- Focus Therapeutic Use
- 09 Oct 2014 New trial record